After treatment with LPS and IL-15, there was a significant increase in protein levels of NF-κB p65 and a significant decrease in inhibitor of NF-κB (IκB) levels in THP-1 monocytes from DM2 patients with or without DN compared to healthy controls (p < 0.05). The gene discussed is IL15; the disease is myotonic dystrophy type 2.